Kimia Biosciences share news and announcements
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹30.05.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹142 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 19.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 8.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,361
Kimia Biosciences share news and announcements
546 announcements, routine notices left out, newest first. Page 9 of 11.
Aug 2018
27 Aug · Meeting
Jul 2018
21 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 7 6 120 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
Jun 2018
11 Jun · Compliance Under Regulation 39(3) Of Listing Regulations, 2015
May 2018
25 May · Board meeting
14 May · Board Meeting On May 25, 2018
Apr 2018
30 Apr · Compliance Certificate In Terms Of Regulation 40 (9 & 10) Of The Listing Regulations, 2015 As On 31St March, 2018
30 Apr · Compliance Certificate As Per Regulation 7(3) Of Listing Regulations, 2015 For The Half Year Ended 31St March, 2018
21 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....19 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Feb 2018
15 Feb · Board meeting
9 Feb · Board meeting
5 Feb · Business
1 Feb · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....1 Feb · Board Meeting On February 09, 2018
Jan 2018
18 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
Dec 2017
21 Dec · Board meeting
18 Dec · Board Meeting Postponed
6 Dec · Results
Details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Nov 2017
23 Nov · Updates
22 Nov · Board Meeting On December 05, 2017
Oct 2017
27 Oct · Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015
26 Oct · NCLT Convened Meetings On November 26, 2017
16 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....16 Oct · Compliance Certificate For The Period Ended On September 30, 2017
Sep 2017
29 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....29 Sep · Management
28 Sep · Meeting